Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 142781

1.

Hepatitis C virus and neurological damage.

Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I.

World J Hepatol. 2016 Apr 28;8(12):545-56. doi: 10.4254/wjh.v8.i12.545. Review.

PMID:
27134702
2.

Wherefore Art Thou, O Treatment for Diabetic Neuropathy?

Malik RA.

Int Rev Neurobiol. 2016;127:287-317. doi: 10.1016/bs.irn.2016.03.008. Epub 2016 Apr 21.

PMID:
27133154
3.

Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy.

Vinik AI, Casellini C, Névoret ML.

Int Rev Neurobiol. 2016;127:235-85. doi: 10.1016/bs.irn.2016.03.010. Epub 2016 Apr 13.

PMID:
27133153
4.

Painful Diabetic Neuropathy: Prevention or Suppression?

Todorovic SM.

Int Rev Neurobiol. 2016;127:211-25. doi: 10.1016/bs.irn.2016.03.005. Epub 2016 Apr 2.

PMID:
27133151
5.

Promoting Neuronal Tolerance of Diabetic Stress: Modulating Molecular Chaperones.

Emery SM, Dobrowsky RT.

Int Rev Neurobiol. 2016;127:181-210. doi: 10.1016/bs.irn.2016.03.001. Epub 2016 Apr 5.

PMID:
27133150
6.

Glucotoxic Mechanisms and Related Therapeutic Approaches.

Yagihashi S.

Int Rev Neurobiol. 2016;127:121-49. doi: 10.1016/bs.irn.2016.03.006. Epub 2016 Apr 8.

PMID:
27133148
7.

Alternatives to the Streptozotocin-Diabetic Rodent.

Yorek MA.

Int Rev Neurobiol. 2016;127:89-112. doi: 10.1016/bs.irn.2016.03.002. Epub 2016 Mar 28.

PMID:
27133146
8.

Gene therapy to target ER stress in brain diseases.

Valenzuela V, Martínez G, Duran-Aniotz C, Hetz C.

Brain Res. 2016 Apr 27. pii: S0006-8993(16)30313-4. doi: 10.1016/j.brainres.2016.04.064. [Epub ahead of print] Review.

PMID:
27131987
9.

Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.

Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, Schmitt M, Opelz G, Terness P.

J Transl Med. 2016 May 1;14(1):99. doi: 10.1186/s12967-016-0860-6.

10.

Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.

Lenherr SM, Clemens JQ, Braffett BH, Cleary PA, Dunn RL, Hotaling JM, Jacobson AM, Kim C, Herman W, Brown JS, Wessells H, Sarma AV; DCCT/EDIC Research Group.

J Urol. 2016 Apr 27. pii: S0022-5347(16)30314-7. doi: 10.1016/j.juro.2016.04.071. [Epub ahead of print]

PMID:
27131462
11.

Altered joint moment strategy during stair walking in diabetes patients with and without peripheral neuropathy.

Brown SJ, Handsaker JC, Maganaris CN, Bowling FL, Boulton AJ, Reeves ND.

Gait Posture. 2016 May;46:188-93. doi: 10.1016/j.gaitpost.2016.03.007. Epub 2016 Mar 19.

12.

Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.

Wong R, Major P, Sagar S.

Integr Cancer Ther. 2016 Apr 29. pii: 1534735415627926. [Epub ahead of print]

PMID:
27130723
13.

Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.

Junqueira SC, Dos Santos Coelho I, Lieberknecht V, Cunha MP, Calixto JB, Rodrigues AL, Santos AR, Dutra RC.

Mol Neurobiol. 2016 Apr 30. [Epub ahead of print]

PMID:
27130268
14.

Levodopa and neuropathy risk in patients with Parkinson disease: Effect of COMT inhibition.

Cossu G, Ceravolo R, Zibetti M, Arca R, Ricchi V, Paribello A, Murgia D, Merola A, Romagnolo A, Nicoletti V, Palermo G, Mereu A, Lopiano L, Melis M, Abbruzzese G, Bonuccelli U.

Parkinsonism Relat Disord. 2016 Apr 20. pii: S1353-8020(16)30120-1. doi: 10.1016/j.parkreldis.2016.04.016. [Epub ahead of print]

PMID:
27129930
15.

Phenotype variability of infantile-onset multisystem neurologic, endocrine, and pancreatic disease IMNEPD.

Picker-Minh S, Mignot C, Doummar D, Hashem M, Faqeih E, Josset P, Dubern B, Alkuraya FS, Kraemer N, Kaindl AM.

Orphanet J Rare Dis. 2016 Apr 29;11(1):52. doi: 10.1186/s13023-016-0433-z.

16.

Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.

Draak TH, Gorson KC, Vanhoutte EK, van Nes SI, van Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

Eur J Neurol. 2016 Apr 29. doi: 10.1111/ene.13025. [Epub ahead of print]

PMID:
27129110
17.

Metronidazole-Induced Cerebellar Toxicity.

Agarwal A, Kanekar S, Sabat S, Thamburaj K.

Neurol Int. 2016 Apr 1;8(1):6365. doi: 10.4081/ni.2016.6365. eCollection 2016 Apr 1.

18.

Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.

Maiese K.

Neural Regen Res. 2016 Mar;11(3):372-85. doi: 10.4103/1673-5374.179032. Review.

19.

Initial Report of Phase II Study on Bi-weekly SOX plus Cetuximab Treatment for Wild-type K-RAS Advanced and Recurrent Colorectal Cancer.

Ogawa M, Anan T, Suzuki T, Okuma M, Ichihara K, Hasegawa T, Yoshida K, Yanaga K.

Anticancer Res. 2016 May;36(5):2505-11.

PMID:
27127165
20.

Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance.

Inoue K, Saito T, Okubo K, Kimizuka K, Yamada H, Sakurai T, Ishizuna K, Hata S, Kai T, Kurosumi M.

Breast Cancer Res Treat. 2016 Apr 28. [Epub ahead of print]

PMID:
27125669
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk